Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Immunoprecipitation | 4 | 2019 | 300 | 1.69 | Why? |
| Autoantibodies | 7 | 2021 | 2094 | 1.30 | Why? |
| Luciferases | 2 | 2019 | 378 | 1.27 | Why? |
| Pancreatic Neoplasms | 3 | 2018 | 609 | 0.94 | Why? |
| Carcinoma, Pancreatic Ductal | 2 | 2018 | 112 | 0.82 | Why? |
| H(+)-K(+)-Exchanging ATPase | 1 | 2019 | 3 | 0.80 | Why? |
| Insulin Antibodies | 1 | 2018 | 9 | 0.74 | Why? |
| Maf Transcription Factors, Large | 1 | 2017 | 2 | 0.74 | Why? |
| Endocrine Gland Neoplasms | 1 | 2017 | 30 | 0.71 | Why? |
| Cytoskeletal Proteins | 1 | 2018 | 63 | 0.70 | Why? |
| Islets of Langerhans | 1 | 2017 | 138 | 0.63 | Why? |
| Diabetes Mellitus, Type 1 | 4 | 2018 | 1969 | 0.63 | Why? |
| Interleukin-2 | 1 | 2017 | 443 | 0.59 | Why? |
| Fluorescent Dyes | 1 | 2018 | 536 | 0.53 | Why? |
| Antigens, Viral | 2 | 2020 | 6298 | 0.51 | Why? |
| Insulin | 3 | 2018 | 1316 | 0.48 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2017 | 584 | 0.48 | Why? |
| Antibody Formation | 3 | 2021 | 4038 | 0.43 | Why? |
| Epitopes | 1 | 2020 | 4113 | 0.35 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.27 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.25 | Why? |
| Diabetes Mellitus | 2 | 2021 | 8207 | 0.23 | Why? |
| Wiskott-Aldrich Syndrome | 1 | 2020 | 41 | 0.22 | Why? |
| Biomarkers, Tumor | 2 | 2018 | 1314 | 0.19 | Why? |
| Glutamate Decarboxylase | 1 | 2018 | 25 | 0.19 | Why? |
| Proinsulin | 1 | 2018 | 9 | 0.19 | Why? |
| Interferon Type I | 2 | 2021 | 2789 | 0.17 | Why? |
| Glycine | 1 | 2019 | 203 | 0.17 | Why? |
| Antigens | 1 | 2019 | 267 | 0.16 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2018 | 192 | 0.16 | Why? |
| Neoplasm Grading | 1 | 2018 | 400 | 0.16 | Why? |
| Genes, Reporter | 1 | 2018 | 472 | 0.16 | Why? |
| Genetic Therapy | 1 | 2020 | 409 | 0.15 | Why? |
| Autoantigens | 1 | 2018 | 388 | 0.14 | Why? |
| Pancreas | 1 | 2018 | 398 | 0.14 | Why? |
| Protein Biosynthesis | 1 | 2019 | 653 | 0.14 | Why? |
| Cloning, Molecular | 1 | 2018 | 1036 | 0.14 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.14 | Why? |
| Case-Control Studies | 4 | 2021 | 17671 | 0.12 | Why? |
| Transcription, Genetic | 1 | 2019 | 1326 | 0.12 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1014 | 0.12 | Why? |
| Diabetes Complications | 2 | 2021 | 2358 | 0.12 | Why? |
| Antibodies, Neutralizing | 5 | 2021 | 25288 | 0.11 | Why? |
| Blood Glucose | 3 | 2021 | 3642 | 0.11 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.11 | Why? |
| Interferon-gamma | 1 | 2021 | 2711 | 0.11 | Why? |
| Neoplasm Staging | 1 | 2018 | 1999 | 0.10 | Why? |
| Hyperglycemia | 1 | 2021 | 1363 | 0.10 | Why? |
| Autoimmunity | 1 | 2017 | 841 | 0.10 | Why? |
| Survival Analysis | 2 | 2020 | 7592 | 0.10 | Why? |
| Phenotype | 2 | 2018 | 4037 | 0.10 | Why? |
| Thromboembolism | 1 | 2021 | 2101 | 0.09 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.08 | Why? |
| Biomarkers | 3 | 2020 | 23361 | 0.08 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.08 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.08 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.08 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.08 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.08 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.07 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.07 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.07 | Why? |
| Aged | 9 | 2021 | 215776 | 0.07 | Why? |
| HEK293 Cells | 1 | 2018 | 8394 | 0.07 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2018 | 2984 | 0.07 | Why? |
| Male | 13 | 2021 | 367725 | 0.06 | Why? |
| Humans | 18 | 2021 | 930598 | 0.06 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.06 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 7868 | 0.06 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.06 | Why? |
| Female | 11 | 2021 | 380317 | 0.06 | Why? |
| Immunoassay | 1 | 2018 | 4485 | 0.06 | Why? |
| Wiskott-Aldrich Syndrome Protein | 1 | 2020 | 37 | 0.06 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.05 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.05 | Why? |
| Adult | 9 | 2021 | 244371 | 0.05 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.05 | Why? |
| Cell Line, Tumor | 2 | 2018 | 3608 | 0.05 | Why? |
| Keratin-19 | 1 | 2018 | 16 | 0.05 | Why? |
| Organogenesis | 1 | 2018 | 24 | 0.05 | Why? |
| Mice, Inbred NOD | 1 | 2018 | 134 | 0.05 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.04 | Why? |
| Homeodomain Proteins | 1 | 2018 | 93 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2018 | 274 | 0.04 | Why? |
| Mice, Nude | 1 | 2018 | 340 | 0.04 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2018 | 501 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2018 | 640 | 0.04 | Why? |
| Insulin-Secreting Cells | 1 | 2018 | 273 | 0.04 | Why? |
| Age of Onset | 1 | 2018 | 557 | 0.04 | Why? |
| Nuclear Proteins | 1 | 2018 | 321 | 0.04 | Why? |
| Fasting | 1 | 2021 | 555 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Child | 3 | 2021 | 70012 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
| Chemokine CXCL10 | 1 | 2018 | 565 | 0.03 | Why? |
| Infant | 3 | 2021 | 30274 | 0.03 | Why? |
| Influenza, Human | 1 | 2018 | 10779 | 0.03 | Why? |
| Interferon-alpha | 1 | 2021 | 1442 | 0.03 | Why? |
| Transcription Factors | 1 | 2018 | 784 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2021 | 2115 | 0.03 | Why? |
| Dogs | 1 | 2018 | 2529 | 0.03 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2021 | 3567 | 0.02 | Why? |
| Mice | 2 | 2018 | 21357 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Cell Line | 1 | 2018 | 12040 | 0.02 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 11367 | 0.01 | Why? |
| Animals | 2 | 2018 | 78931 | 0.01 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Stress, Psychological | 1 | 2021 | 10231 | 0.01 | Why? |
| Italy | 1 | 2021 | 38444 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| RNA, Viral | 1 | 2018 | 32276 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Betacoronavirus | 2 | 2021 | 204454 | 0.00 | Why? |
Lampasona's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(343)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_